|
|
Volumn 5, Issue 1, 1998, Pages 45-52
|
|
Neonatal outcome in pregnancies associated with renal replacement therapy
|
|
Author keywords
Dialysis; Kidney transplantation; Neonatal mortality; Teratogen
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTIMETABOLITE;
AZATHIOPRINE;
CALCIUM CHANNEL BLOCKING AGENT;
CORTICOSTEROID;
CYCLOSPORIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
PREDNISONE;
RECOMBINANT ERYTHROPOIETIN;
TACROLIMUS;
ANEMIA;
ANTIHYPERTENSIVE THERAPY;
CLINICAL TRIAL;
CONGENITAL MALFORMATION;
DIALYSIS;
DRUG INDUCED DISEASE;
FETUS MALFORMATION;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LOW BIRTH WEIGHT;
MULTICENTER STUDY;
NEPHROTOXICITY;
NEWBORN;
PREGNANCY;
PREMATURE LABOR;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
TERATOGENICITY;
TREATMENT OUTCOME;
|
|
EID: 0031933708
PISSN: 10734449
EISSN: None
Source Type: Journal
DOI: 10.1016/S1073-4449(98)70014-7 Document Type: Article |
|
Times cited : (16)
|
|
References (42)
|
